Prior authorization — indicate covered indications

Prior authorization may be required for double balloon enteroscopy (DBE). When prior authorization is requested, clearly indicate that the procedure is being performed for one of the medically necessary indications listed in the policy (e.g., dilation of Crohn’s small-bowel strictures; suspected small-bowel malignancy; incomplete colonoscopy evaluation; suspected Meckel’s diverticulum with indeterminate imaging; investigation of obscure GI bleeding after negative EGD/colonoscopy; initial diagnosis of suspected Crohn’s when conventional tests are negative; removal of retained capsule/foreign body; polypectomy in Peutz‑Jeghers; or DBE to treat a documented small‑intestinal source of bleeding).

• List the specific indication in the authorization request and attach relevant records (see documentation callouts).
• If the indication is not one of the listed medically necessary uses, state that DBE is considered experimental/investigational and may be denied.

Prior testing and justification

Document prior diagnostic testing and rationale in the request. Capsule endoscopy (CE/VCE) is commonly the recommended initial diagnostic test for obscure GI bleeding and often guides the route and yield of subsequent DBE; when CE is positive, DBE diagnostic yield is substantially higher. If DBE is being requested without prior CE, provide justification (e.g., active/hemodynamically significant bleeding requiring immediate intervention, contraindication to CE, or clinical urgency).

• Attach results/images from prior CE when available.
• If CE was negative but clinical suspicion remains high, include explanation and supporting data (ongoing bleeding, transfusion requirement, or imaging suggesting a lesion).

Prior authorization for DBE in specialized indications

Prior authorization should be requested for specialized indications where DBE is used for definitive therapy or complex diagnostic situations (for example, surveillance and polypectomy of large small-bowel polyps in Peutz‑Jeghers syndrome, or pre-operative localization of suspected small‑bowel malignancy). Provide disease-specific documentation to support medical necessity.

• For Peutz‑Jeghers syndrome, include prior imaging (MRE/CT) and polyp size/number and rationale for enteroscopic polypectomy.
• For suspected malignancy, include imaging, tumor markers, or other findings suggesting neoplasm.

Prior authorization recommended for complex DBE interventions

Recommend prior authorization for DBE procedures that are complex or combined with other high‑risk interventions (for example, DBE‑ERCP or enteroscopy‑assisted ERCP in patients with surgically altered anatomy). These procedures have higher technical complexity and complication rates and may warrant review prior to scheduling.

• When requesting DBE‑ERCP, include prior operative reports describing surgical anatomy (e.g., Roux‑en‑Y, hepaticojejunostomy), prior ERCP attempts, and rationale for enteroscopic approach.
• State anticipated interventions (sphincterotomy, stone removal, stent placement) and provide relevant imaging/labs.

Coding and indication mismatch

DBE coding does not have a single, unique CPT code; related CPT/HCPCS codes may be submitted depending on the route and any concurrent procedures (diagnostic enteroscopy, polypectomy, ERCP codes, dilation, foreign‑body removal). Ensure that selected codes match the documented indication and interventions to avoid coding/coverage mismatches.

• Include narrative describing route (antegrade vs retrograde), procedures performed (biopsy, polypectomy, dilation, foreign‑body extraction), and corresponding CPT/HCPCS codes.
• If using ERCP CPT/HCPCS codes with enteroscopy, document that papilla/anastomosis was reached and ERCP maneuvers performed.

Technical failure leading to unsuccessful ERCP

If DBE‑assisted ERCP or enteroscopy fails to reach the papilla or anastomosis, document all attempted routes, technical obstacles (afferent limb entered but anastomosis not reached, angulation, jejunojejunostomy not identified), and reasons for procedural failure. This information is important for claims adjudication and to justify alternative or repeat procedures.

• Include operative/procedure note detailing routes attempted (oral/anal), length advanced, and specific anatomic/technical barriers.
• If cannulation failed after reaching the target, document cannulation attempts and methods used.

Risks that may prompt payer review

DBE‑ERCP and other enteroscopy‑assisted complex interventions carry higher complication rates (including perforation, pancreatitis, cholangitis, bleeding). Requests for high‑risk procedures may be scrutinized; include risk–benefit discussion and prior less‑invasive options attempted.

• List patient comorbidities that increase procedural risk.
• Provide rationale why alternative modalities (percutaneous or surgical) are less desirable or not feasible.

None specified in this section

This policy excerpt does not specify additional plan-level step‑therapy requirements or quantity limits for DBE. Providers should still follow standard prior authorization processes and supply complete documentation to support medical necessity.

• If plan documents elsewhere impose step therapy, that requirement is separate and must be followed.

Indication documentation

Indication documentation: when submitting a request, include the clinical indication and demonstrate it matches one of the policy's medically necessary indications. Provide presenting symptoms (e.g., overt/obscure GI bleeding, iron‑deficiency anemia, abdominal pain), prior endoscopic findings, and any supporting lab or imaging results.

• Cite prior EGD/colonoscopy reports showing failure to identify bleeding source for OGIB indications.
• For Crohn’s dilation, document stricture length, symptoms, and imaging/endoscopic correlation.

Required procedural documentation

Required procedural documentation: include the indication, pre‑procedure diagnostic findings (e.g., positive CE), detailed procedure note describing route(s) attempted, depth/length advanced, interventions performed (biopsy, polypectomy, dilation, APC, tattooing, foreign‑body extraction), complications, and post‑procedure plan.

• Attach CE images/reports if available and pathology results for biopsies.
• If multiple procedures were performed in one session, itemize each and supply corresponding documentation to support coding.

Suggested supporting documentation

Suggested supporting documentation: include prior diagnostic work‑up (CE, CT/MR enterography, Meckel’s scan, small‑bowel follow‑through), laboratory data (hemoglobin, iron studies), transfusion history, and prior procedure reports that establish persistence of symptoms or ongoing bleeding.

• For suspected Meckel’s diverticulum, include Meckel’s scan results and rationale for proceeding to DBE if scan was negative but suspicion remains.
• For OGIB, provide serial hemoglobin trends and transfusion needs.

Use diagnostic algorithm

Use a diagnostic algorithm: in obscure GI bleeding, perform standard upper and lower endoscopies first; CE is generally the preferred initial small‑bowel diagnostic test because it is noninvasive and can direct DBE route selection; DBE is often used for therapy or biopsy after CE localization.

• If CE is positive, include CE findings to justify targeted DBE.
• If CE is not performed, document contraindication or clinical urgency requiring direct DBE.

Use of capsule endoscopy before DBE

Use of capsule endoscopy before DBE: CE is generally recommended as the initial diagnostic test for obscure GI bleeding due to its ability to visualize the entire small bowel and to guide subsequent DBE; when DBE is requested following a positive CE, diagnostic yield is higher.

• Attach CE report/images if available to prior authorization request.
• When CE showed only blood in lumen, note that DBE may clarify the source in a substantial proportion of cases.

Consider referral/step-up to specialized center

Consider referral/step‑up to a specialized or high‑volume center when ERCP is required in patients with surgically altered anatomy or when prior enteroscopy attempts have failed. High‑volume centers may achieve higher enteroscopic and ERCP success rates and lower need for alternative invasive procedures.

• If local facility lacks DBE‑ERCP capability, document referral attempts or rationale for out‑of‑network care.
• Include prior unsuccessful attempts and reasons when requesting authorization for referral.

Noninvasive studies prior to DBE

Noninvasive studies prior to DBE: consider CT or MR enterography, Meckel’s scan (for suspected Meckel’s), angiography when active bleeding is suspected, and CE as part of the diagnostic work‑up; include these results in the authorization request to support necessity of DBE.

• For Meckel’s suspicion, include Meckel’s scan and CT/MR findings; note that BAE/DBE may be preferred when other modalities are indeterminate.
• If imaging suggests a lesion amenable to endoscopic therapy, document findings and prior noninvasive test dates.

No step therapy requirements are specified

No step therapy requirements for DBE are specified within this policy excerpt. Providers should follow the payer's general authorization processes and any other plan‑specific utilization management rules that may apply.

• If a plan's medical management system indicates step requirements elsewhere, comply with those external requirements.